4Filed Aug 17, 8:00 PM ET
RECURSION (RXRX) CFO Ben Taylor Withholds 25,018 Shares for Taxes
$RXRX · RECURSION PHARMACEUTICALS, INC.Research Summary
AI-generated summary of this SEC filing
RECURSION (RXRX) CFO Ben Taylor Withholds 25,018 Shares for Taxes
What Happened
- Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals, had 25,018 shares withheld by the company to satisfy tax withholding obligations in connection with the net settlement of restricted stock units (RSUs). The withholding was recorded at $3.16 per share, totaling approximately $79,057. This is a tax-withholding disposal (code F), not an open-market sale.
Key Details
- Transaction date: 2026-08-17; Filing date: 2026-08-18 (filed next business day).
- Shares withheld/disposed: 25,018 at $3.16 per share; total value about $79,057.
- Transaction type/code: F — shares withheld to satisfy tax withholding on RSU net settlement.
- Post-transaction holdings: Not specified in this Form 4 filing.
- Footnote: F1 — shares were withheld by the issuer to satisfy its tax withholding and remittance obligations for the net settlement of restricted stock units.
- Timeliness: Filing appears timely (reported next business day); not marked as late.
Context
- This was a routine tax-withholding event tied to RSU vesting (net settlement), where the company retains a portion of vested shares to cover taxes. Such withholdings are administrative and generally do not signal a deliberate insider sale or change in sentiment.